The DEA must re-classify cannabidiol (CBD) before the medication can be available to patients. On Monday, the Food and Drug Administration (FDA) approved Epidiolex, a cannabidiol (CBD) treatment for debilitating epilepsy beginning in children as young as 1 or even younger. Cannabidiol is a chemical compound (cannabinoid) of the cannabis plant known for its pain-relieving… Continue reading FDA Approves First Cannabis-Based Drug For Debilitating Seizures
Recovery IS possible and YOU deserve it ❤️